PE23.06LB HIV prevention research and development funding trends 2000'2019: investment priorities to fund innovation in a challenging global health landscapeE-posterPolicy and advocacy
PE23.07LB Planning for voluntary medical male circumcision (VMMC) program sustainability: generating evidence to support targeted transition planning in Zambia and Zimbabwe using the VMMC Transition Assessment Dashboard-VTADE-posterPolicy and advocacy
PE24.01 Efficacy of a vaginal ring containing the gp120 blocker DS003 in pigtailed macaquesE-posterPreclinical studies for HIV prevention
PE24.02 Transport and permeability properties of dapivirine: understanding potential drug-drug interactionsE-posterPreclinical studies for HIV prevention
PE24.04LB Dose response to tenofovir disoproxil fumarate and tenofovir released via intravaginal ring in the sheep vaginal safety and pharmacokinetics modelE-posterPreclinical studies for HIV prevention
PE24.05LB Induction of neutralization breadth and broadly neutralizing antibody lineage responses in HIV envelope BG505 SOSIP immunized infant macaquesE-posterPreclinical studies for HIV prevention
PE25.01 What women want in a multipurpose vaginal ring: findings from a phase 1 trial in the U.S. and the Dominican RepublicE-posterProduct acceptability and adherence
PE25.02 Impact of women's home environment on use of the dapivirine ring for HIV prevention in MTN-025/HOPEE-posterProduct acceptability and adherence
PE25.03 Patterns of adherence among South African women in a phase III randomized controlled trial of a dapivirine vaginal ring for HIV-1 preventionE-posterProduct acceptability and adherence
PE25.05 Utilization patterns and HIV incidence within the first year of initiation of FTC/TDF for HIV pre-exposure prophylaxis (PrEP) among insured persons in the USE-posterProduct acceptability and adherence
seek-warrow-warrow-eseek-e411 - 420 of 444 items